Phoebe Mounts - Feb 18, 2022 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
General Counsel
Signature
/s/ Phoebe Mounts
Stock symbol
CRMD
Transactions as of
Feb 18, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 03:10 PM
Previous filing
Nov 3, 2021
Next filing
Jan 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRMD Common Stock 7.2K Feb 18, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy) Award $0 +140K $0.00 140K Feb 18, 2022 Common Stock 140K $4.03 Direct F6
holding CRMD Stock Option (Right to Buy) 100K Feb 18, 2022 Common Stock 100K $5.56 Direct F1
holding CRMD Stock Option (Right to Buy) 140K Feb 18, 2022 Common Stock 140K $8.32 Direct F2
holding CRMD Stock Option (Right to Buy) 50K Feb 18, 2022 Common Stock 50K $5.63 Direct F3
holding CRMD Stock Option (Right to Buy) 50K Feb 18, 2022 Common Stock 50K $4.08 Direct F3
holding CRMD Stock Option (Right to Buy) 24.8K Feb 18, 2022 Common Stock 24.8K $5.63 Direct F4
holding CRMD Stock Option (Right to Buy) 70K Feb 18, 2022 Common Stock 70K $7.92 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on 11/1/2021. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
F2 These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones.
F3 These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
F4 These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
F5 The options vest as follows: 42,000 vest in equal fourths on May 1 of each of 2020, 2021, 2022 and 2023 and 28,000 vest upon the achievement of designated milestones.
F6 These options were granted on 2/18/2022. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

Remarks:

The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.